Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Moderna's COVID-19 vaccine goes into final human trial stage
  • World

    Moderna's COVID-19 vaccine goes into final human trial stage

    Shubham Sharma
    Written by
    Shubham Sharma
    Twitter
    Last updated on Jul 27, 2020, 09:12 pm
    Moderna's COVID-19 vaccine goes into final human trial stage
  • In a major development, the COVID-19 vaccine developed by biotech giant Moderna Therapeutics has gone into the third and final stage of clinical human trials.

    The late-stage study, first one to have started by the United States, is the last step before the vaccine candidate is lined up for regulatory review and emergency-use approvals.

    Here are the details of the trial.

  • In this article
    Vaccine being tested on 30,000 participants What will happen in the trial? Participants will be monitored in the months to come So far, the results have been promising Here is what NIAID's Director says on the Phase-3 trial Possible availability in early 2021
  • Trial

    Vaccine being tested on 30,000 participants

    Vaccine being tested on 30,000 participants
  • As part of the Phase-3 trial, Moderna is administering its experimental shot, dubbed mRNA-1273, on as many as 30,000 volunteers - people who are healthy and have not been infected by the novel coronavirus disease.

    The trial is set across 89 US sites, including the Washington DC and some worst-hit regions like Texas, California, Florida, Georgia, Arizona, and North and South Carolina.

  • Details

    What will happen in the trial?

  • The study, as explained by Moderna, is a randomized, observer-blind, placebo-controlled trial to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19 for up to 2 years.

    Under this, a select group of participants will get two 100 microgram shots of the vaccine in a gap of 28 days, while the others, a control group, will get a placebo for comparison.

  • Monitoring

    Participants will be monitored in the months to come

    Participants will be monitored in the months to come
  • Once the participants are injected, they will be allowed to go about their daily routines and monitored/tested to see how effectively and safely the shot works on them.

    The main goal of the study is to see if the vaccine could prevent COVID-19 symptoms after two doses, while the secondary objectives include whether it could prevent severe COVID-19 case or death caused by it.

  • Results

    So far, the results have been promising

  • The Moderna vaccine, developed jointly by Moderna and US NIAID, has seen some delays to go into the final trials, but the results from early-stage tests have shown promise.

    In the Phase-1, the shot was tested on 45 healthy volunteers and was able to generate an immune response against the virus in all the cases, without any major side effects.

  • Quote

    Here is what NIAID's Director says on the Phase-3 trial

  • "Results from early-stage clinical testing indicate the investigational mRNA-1273 vaccine is safe and immunogenic," said Dr. Anthony Fauci, NIAID's Director. "This scientifically rigorous, randomized, placebo-controlled trial is designed to determine if the vaccine can prevent COVID-19 and for how long such protection may last."

  • Availability

    Possible availability in early 2021

    Possible availability in early 2021
  • If all goes according to the plan and the vaccine achieves the primary and secondary objectives, the data generated from the late-stage trial will be submitted to the Food and Drug Administration (FDA) for review.

    After that, the authority should issue emergency use authorization for the vaccine, possibly making it available for public use by early 2021.

  • Washington DC
  • South Carolina
  • United States of America
  • Food and Drug Administration
  • NIAID
  •  
Latest News
  • IPL 2021: Richardson comes in for RCB; RR include Gopal
    IPL 2021: Richardson comes in for RCB; RR include Gopal
    Sports
  • IPL 2021, RCB vs RR: Virat Kohli elects to field
    IPL 2021, RCB vs RR: Virat Kohli elects to field
    Sports
  • Coronavirus: Modi chairs key meeting on oxygen availability amid shortage
    Coronavirus: Modi chairs key meeting on oxygen availability amid shortage
    India
  • 'Sardar Ka Grandson' trailer: Arjun Kapoor literally brings home closer
    'Sardar Ka Grandson' trailer: Arjun Kapoor literally brings home closer
    Entertainment
  • "Only two hours' oxygen left": Delhi hospital chief breaks down
    "Only two hours' oxygen left": Delhi hospital chief breaks down
    India
Related Timelines
  • US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
    US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
    World
  • Moderna's COVID-19 vaccine found to be 95% effective: Details here
    Moderna's COVID-19 vaccine found to be 95% effective: Details here
    Science
  • Johnson & Johnson's COVID-19 vaccine goes into final human trials
    Johnson & Johnson's COVID-19 vaccine goes into final human trials
    World
  • Novavax's COVID-19 vaccine goes into mid-stage human trials: Details here
    Novavax's COVID-19 vaccine goes into mid-stage human trials: Details here
    World
Trending Topics
Kamala Harris Coronavirus
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Microsoft Indian Premier League Samsung Virat Kohli
Rohit Sharma Cricket News YouTube Hollywood News WhatsApp Netflix Bollywood News ISRO Yoga Honda
Batman Football News BMW Vaccine Reliance Jio OPPO Amazon Food News, Healthy Recipes Apple Royal Challengers Bangalore
Toyota Fashion Tips Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers
Neha Kakkar X-Men TATA Eoin Morgan
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021